Congratulations CMAJ on adding to the fear of myopathy with statin therapy based on the article by Mohaupt et al (July 7). Nowhere is it mentioned how frequent statin myopathy might be. And in the groups with statin myopathy, most were concurrently taking drugs known either to cause myopathy or increase the risk with statin therapy. So, what comes out in the popular press: “Cholesterol pills can be a pain”; “Cholesterol drugs linked to long-lasting muscle injury”. Why didn’t the reviewers and editors of CMAJ ask to see more results on patients with myopathy just on statins? For now, patients will be stopping medications without physician supervision or questioning their physicians’ judgment and recommendations.
Footnotes
-
For the full letter go to: www.cmaj.ca/cgi/eletters/181/1-2/E11#140400